Chang'ao Pharmaceutical Technology Company has the following competitive advantages: (1) Strong management team We have a strong management team with extensive professional experience.

Mr. Gao Bin is our executive chairman and the company's controlling shareholder. He has more than 20 years of pharmaceutical marketing experience in China. He has established a strong and effective management team for our company.

Half of the company's management team's senior managers have more than 20 years of experience in the pharmaceutical business in China.

(2) Effective marketing team and extensive distribution network We have an efficient marketing team of more than 1,000 people and an extensive distribution network covering the entire China, which allows us to quickly distribute pharmaceutical products to a wide range of retailers.

Sales, thereby enabling our and other third party pharmaceutical products to be sold in various provinces, municipalities and autonomous regions in China.

The key to our marketing strategy is to find potential markets in China and carry out promotion and marketing through agents or ourselves.

Each sales team is responsible for coordinating the company's marketing activities in the provinces it is responsible for. These sales teams are given great autonomy, allowing us to make rapid and flexible responses to the changes in various sales markets in China.

(3) Strong R&D capabilities Our company has strong R&D capabilities. We can conduct most of the product R&D work within the company without having to seek help from other companies and sell our own R&D results.

Our strong R&D capabilities enable us to conduct research and development of more than 50 potential new products at the same time, and provide a strong foundation for Changao's brand products.

We have more than 80 researchers, and we also have an advisory group of 6 consultants who have rich knowledge and extensive experience to assist us in product research and development.

(4) GMP certified product production process Our production process is GMP certified. We implement a strict quality management system to ensure that the production process complies with national standards and procedures.

(5) The national pharmaceutical product plan lists Aomei products and more than 10 Chang'ao brand products (such as Amorin, Junbiqing, Cefradine for Injection, Aoshu, Ximei, Kexinlin, Aofen, Fusitan

, Lizhixue, Libase, Jianao, Aoweisu and Yumalin) are all listed in the national basic medical insurance and work-related injury insurance drug catalog issued by the Ministry of Labor and Social Security of the People's Republic of China.

This allows the product to sell well, because the costs of the drugs listed on the list are covered by the national health insurance, and people who enjoy health insurance will naturally choose the drugs listed on the list.

(6) Technological innovation has been recognized. The products of Changao Pharmaceutical Technology Co., Ltd. have been recognized by the market in terms of technological innovation.